|
Adverse Effects
Citations 61-70 of 266 total displayed.
|
Past content
(since May 1999):
|
- Observations
Severe Dermatomyositis Triggered by Interferon Beta-1a Therapy and Associated With Enhanced Type I Interferon Signaling
- Ally-Khan Somani; Alan R. Swick; Kevin D. Cooper; Thomas S. McCormick
Arch Dermatol 2008; 144: 1341-1349.
[Abstract]
[Full text]
[PDF]
- Editorials
Type I Interferon in the Induction or Exacerbation of Dermatomyositis: What This Observation Tells Us About the Naturally Occurring Disease
- David F. Fiorentino
Arch Dermatol 2008; 144: 1379-1382.
[Extract]
[Full text]
[PDF]
- Correspondence
Efalizumab-Associated Guillain-Barré Syndrome
- Frank Victor; Kavita Menon; Jo-Ann M. Latkowski; Adolfo Fernandez-Obregon; Bruce E. Strober
Arch Dermatol 2008; 144: 1396-1397.
[Extract]
[Full text]
[PDF]
- Correspondence
Imatinib-Induced Hand-Foot Syndrome in a Patient With Metastatic Gastrointestinal Stromal Tumor
- Maxime Battistella; Guillemette Frémont; Marie-Dominique Vignon-Pennamen; Jean-Marc Gornet; Louis Dubertret; Manuelle Viguier
Arch Dermatol 2008; 144: 1400-1402.
[Extract]
[Full text]
[PDF]
- Correspondence
Eccrine Squamous Syringometaplasia Secondary to Pegylated Liposomal Doxorubicin
- Xavier Garcia-Navarro; Lluis Puig; Maria T. Fernández-Figueras; Agustíin Alomar
Arch Dermatol 2008; 144: 1402-1403.
[Extract]
[Full text]
[PDF]
- Correspondence
Recurrent Hyperglycemia During Adalimumab Treatment in a Patient With Psoriasis
- Jia-Jen Wu; Tsen-Fang Tsai
Arch Dermatol 2008; 144: 1403-1404.
[Extract]
[Full text]
[PDF]
- Observations
Immediate Type I Hypersensitivity Response Implicated in Worsening Injection Site Reactions to Adalimumab
- Michael Paltiel; Laura M. Gober; April Deng; Jamal Mikdashi; Irena Alexeeva; Sarbjit S. Saini; Anthony A. Gaspari
Arch Dermatol 2008; 144: 1190-1194.
[Abstract]
[Full text]
[PDF]
- Evidence-Based Dermatology: Research Commentaries
Does Isotretinoin Increase the Risk of Depression?
- Michael Bigby
Arch Dermatol 2008; 144: 1197-1199.
[Extract]
[Full text]
[PDF]
- Correspondence
Pimecrolimus: A Novel Treatment for Cetuximab-Induced Papulopustular Eruption
- Elisabeth Eiling; Michael Brandt; Thomas Schwarz; Axel Hauschild
Arch Dermatol 2008; 144: 1236-1238.
[Extract]
[Full text]
[PDF]
- Correspondence
The Use of Patch Tests in Determining Hypersensitivity to Etanercept and Infliximab
- Lidian L. A. Lecluse; Gamze Piskin; Jan D. Bos
Arch Dermatol 2008; 144: 1070-a-1071-a.
[Extract]
[Full text]
[PDF]
|
|
